Skip to search formSkip to main contentSkip to account menu

MK-7965

Known as: CDK inhibitor SCH 727965 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

dinaciclib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
andomized phase 2 study of the cyclin-dependent kinase inhibitor inaciclib ( MK-7965 ) versus erlotinib in patients with non-small cell ung cancer
Objectives: Dinaciclib (MK-7965, formerly SCH 727965), a novel, small-molecule inhibitor of cyclindependent kinases, has been… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)